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Introduction: The advent of hyperpolarized MR allows for study of real-time metabolism and offers the possibility to determine the kinetics of 
specific biochemical transformations in vivo [1]. It has been shown that the uptake and conversion of acetate, a main energy source in humans and 
rodents [2], can be probed in muscles after being hyperpolarized [3]. The enzymatic conversion of acetate to acetylcarnitine is dependent on the 
enzymatic activities of carnitine acetyl transferase (CAT) and acetylCoA synthetase (ACS), where carnitine plays an essential role in buffering 
acetylCoA [4,5]. Biochemical reaction rates and enzymatic activities reflect tissue health and are usually determined in vitro. The aim of the present 
study was to characterize the dynamics of hyperpolarized acetate metabolism in skeletal muscle in vivo and to determine the corresponding 
Michaelis-Menten kinetic parameters KM   and Vmax of the transformation involving both CAT and ACS enzymes. 
 
Materials and methods: [1-13C]acetate samples (4.5M) solved in a 1:2 mixture of d6-EtOD/D2O containing 30mM TEMPO free radical were turned 
into frozen glassy beads and subsequently polarized in a custom-designed DNP polarizer for 2.5 h [6]. After dissolution, the samples were transferred 
within 2 s into a home-built infusion pump located inside the magnet bore and connected to a catheter inserted into a rat femoral vein. The 5 s long 
infusion of 1 mL hyperpolarized acetate solution was triggered 1 s later. The whole procedure was computer controlled in order to obtain an identical 
timing for all experiments. At the end of the in vivo acquisition, the residual solution that was left in the infusion pump was extracted and measured 
in a high-resolution 400 MHz spectrometer (Bruker) to determine the exact acetate concentration. Series of single pulse acquisitions were recorded 
using 30° adiabatic RF pulses applied every 3 s starting at the end of the infusion with a homebuilt surface coil. A two-compartment non-steady state 
metabolic model for one-site exchange was used to fit the hyperpolarized time courses and determine the kinetic rate constants k of the biochemical 
reaction and the initial reaction rates V0. The model takes into account the effect of the 30° excitation pulses on the signals decay. The longitudinal 
relaxation time of [1-13C]acetylcarnitine which was measured in blood at physiological temperature was fixed in the fitting procedure, leaving only 2 
free parameters (k and the characteristic decay constant of acetate, which is a combination of T1 and substrate inflow). 
 
Results and discussion: The concentration of the 1 mL hyperpolarized [1-13C]acetate bolus ranged from 30 mM to 200 mM and the time evolution of 
both substrate and product were measured in vivo in 17  different animals. Peak areas were measured by line fitting in jMRUI and a typical time 
course of the metabolic signals is displayed in figure 1. The in vitro T1 of [1-13C]acetylcarnitine in blood at T = 310 K was determined to be 14.9±0.1 
s and used as a constant.  Considering the concentration of the bolus, we assumed that the acetate pool can be approximated as fully labeled. Since 
the pool size of acetyl-CoA is substantially smaller than the acetylcarnitine pool [7], we assumed a unidirectional labeling of the acetylcarnitine pool 
during the short experimental time. As shown in Fig.1, the two-parameter model fits the time evolution quite accurately. Using this model, the kinetic 
rate constants were obtained as a function of hyperpolarized substrate concentration and this relation is displayed in Fig. 2, left panel. The tissue 
concentrations were obtained by dividing the amount of injected acetate by the animal volume.  The determined kinetic rate constants represent both 
CAT and ACS activities. A fit to a Michaelis-Menten type model resulted in Vmax = 3.4 ± 0.8 μM/s and KM = 0.39 ± 0.19 mM (Fig. 2, right panel). 
 
Conclusion: We conclude that the method described above can robustly characterize enzymatic activities in vivo in healthy skeletal muscle and that 
this method could be used to highlight pathological metabolism. 
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Fig. 1: Example of acetate and acetylcarnitine signal 
integrals vs. time. The data were fitted with the
metabolic model to extract the kinetic rate constant. 
 
Fig. 2: Kinetic rate constants k (left) and initial reaction rates V0 (right) as a function of
the tissue concentration. The data were fitted to a Michaelis-Menten kinetic model with
parameters KM and Vmax. The inset is a Lineweaver-Burk plot of the same data.  
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